BBWI250103C39000
- 0.02
- 0.000.00%
Bath & Body Works Newsroom
Bath & Body Works Analyst Ratings
Piper Sandler Maintains Neutral on Bath & Body Works, Raises Price Target to $39
Piper Sandler Maintains Bath & Body Works(BBWI.US) With Hold Rating, Raises Target Price to $39
Goldman Sachs Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $52
Analysts Conflicted on These Consumer Cyclical Names: Bath & Body Works (BBWI) and Vail Resorts (MTN)
Bath & Body Works Is Maintained at Buy by TD Cowen
Bath & Body Works Analyst Ratings
Wells Fargo Maintains Bath & Body Works(BBWI.US) With Hold Rating, Raises Target Price to $42
Wells Fargo Reaffirms Their Hold Rating on Bath & Body Works (BBWI)
TD Cowen Maintains Bath & Body Works(BBWI.US) With Buy Rating, Raises Target Price to $48
A Quick Look at Today's Ratings for Bath & Body Works(BBWI.US), With a Forecast Between $34 to $52
Barclays raises Bath & Body Works' target price to $34.
Bath & Body Works Price Target Raised to $38.00/Share From $32.00 by Wells Fargo
Barclays Maintains Underweight on Bath & Body Works, Raises Price Target to $34
Bath & Body Works Is Maintained at Neutral by Piper Sandler
A Quick Look at Today's Ratings for Bath & Body Works(BBWI.US), With a Forecast Between $34 to $52
Hold Rating for Bath & Body Works Amid Revenue Growth and Margin Concerns
Bath & Body Works: Strong Growth Prospects and Strategic Innovation Drive Buy Rating
Telsey Advisory Group Maintains Outperform on Bath & Body Works, Maintains $42 Price Target
Bath & Body Works Analyst Ratings